Home About Products & Services News Research Investors Contact


Mark R. Bausinger, Chief Financial Officer

Mr. Bausinger has more than 25 years of experience in finance and administration. He was previously CFO at Neuron Therapeutics and Medecision Inc., a healthcare management software company. He has held VP-level positions at US Bioscience, Inc. and the Beecham Group plc (now GlaxoSmithKline). Mr. Bausinger was also the Director of Finance for the Pharmaceutical Division of Centocor, Inc.

Back

Find a NeuroStar TMS Therapy Provider Near You

If you or a loved one is suffering from major depression, you can find a NeuroStar TMS Therapy provider in your area.

Provide NeuroStar TMS Therapy in Your Practice

Provide your patients the new way back with NeuroStar TMS Therapy®. Contact us to find out how you can begin providing therapy.

This link provides you with access to recent published information and news about NeuroStar TMS Therapy and new options for the treatment of depression. Neuronetics does not provide any assurances of the accuracy of this information and may not agree with the opinions of the authors.

NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. To return to the Neuronetics website for full safety and prescribing information click here.

Click here to continue.